dilithium;oxygen(2-)

• 分子结构分类: 无机化合物 - 混合金属/非金属化合物 - 碱金属有机物
• 英文名称: dilithium;oxygen(2-)
• 化学式: Li2O
• 分子量: 29.9
• InChiKey: FUJCRWPEOMXPAD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -6.11
• 重原子数：
  3
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  1
• 氢给体数：
  0
• 氢受体数：
  1

ADMET

毒理性

• 副作用

神经毒素 - 其他中枢神经系统神经毒素 肾毒素 - 该化学物质在工作环境中可能对肾脏有毒。 皮肤毒素 - 皮肤烧伤。 中毒性肺炎 - 由于吸入金属烟雾或有毒气体和蒸气引起的肺部炎症。

Neurotoxin - Other CNS neurotoxin Nephrotoxin - The chemical is potentially toxic to the kidneys in the occupational setting. Dermatotoxin - Skin burns. Toxic Pneumonitis - Inflammation of the lungs induced by inhalation of metal fumes or toxic gases and vapors.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

反应信息

• 作为反应物：
  描述：

  dilithium;oxygen(2-) 生成 lithium;oxido(oxo)alumane
  参考文献：
  名称：

  SMEETS, A. A. J.;FRAY, D. J.;CHARLES, J. A., PROC. INT. SYMP. COMPUT. SOFTWARE CHEM. AND EXTR. MET., MONTREAL, AUG. 28+

  摘要：

  DOI：
• 作为产物：
  描述：

  lithium perchlorate 生成 dilithium;oxygen(2-)
  参考文献：
  名称：

  MERMOUX, M.;TOUZAIN, PH., J. POWER SOURCES, 26,(1989) N-4, C. 529-534

  摘要：

  DOI：

文献信息

• Process and apparatus for isotope determination of condensed phase samples
  申请人：May Michael

  公开号：US20080035840A1

  公开（公告）日：2008-02-14

  A process for isolating a carbon fraction representative of the carbon contained in a specimen of a condensed phase carbonaceous composition. The carbon fraction is isolated in the form of a carbon oxide gas that may be introduced into a mass spectrometer for determining the proportion of the carbon isotope content of the composition that is constituted by 13 C. A novel apparatus is provided which is useful in conducting the process.

  一种用于分离碳质凝聚相物质样品中的碳分数的方法。该碳分数以碳氧化物气体的形式分离出来，可以引入质谱仪中，以确定由13C组成的物质的碳同位素含量比例。还提供了一种新型设备，可用于进行该过程。
• Process and apparatus for 15-nitrogen isotope determination of condensed phase samples
  申请人：May Michael

  公开号：US20070284523A1

  公开（公告）日：2007-12-13

  A novel apparatus and process for isolating a nitrogen fraction representative of the nitrogen contained in a specimen of a condensed phase nitrogenous organic composition. In the process the nitrogen fraction is isolated in the form of a dinitrogen gas that may be introduced into a mass spectrometer for determining the proportion of the nitrogen isotope content of the composition that is constituted by 15 N.

  一种新型的装置和过程，用于分离代表凝聚相氮有机物质中所含氮的氮分数。在该过程中，氮分数以二氮气体的形式分离出来，可以引入质谱仪中，以确定组成15N的氮同位素含量在该物质中所占比例。
• THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS
  申请人：Bardiot Dorothée

  公开号：US20120059028A1

  公开（公告）日：2012-03-08

  The present invention relates to a series of compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutic amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

  本发明涉及一系列具有抗病毒活性的化合物，更具体地说是具有抑制人类免疫缺陷病毒（HIV）复制的特性。本发明还涉及制备这种化合物的方法，以及在这些合成步骤中有用的新型中间体。本发明还涉及含有这种化合物作为活性成分的有效剂量的制药组合物。此外，本发明还涉及将这种化合物用作药物或用于制造对治疗患有病毒感染，特别是HIV感染的动物有用的药物。此外，本发明还涉及通过给予治疗量的这种化合物的管理，可选地与一个或多个具有抗病毒活性的其他药物结合，用于治疗动物的病毒感染的方法。
• SUPPORTED COBALT CATALYSTS FOR THE FISCHER TROPSCH SYNTHESIS
  申请人：BISHOP Peter Trenton

  公开号：US20120190758A1

  公开（公告）日：2012-07-26

  A process for the synthesis of hydrocarbons by the Fisher Tropsch process includes reacting a mixture of carbon monoxide and hydrogen at elevated temperature and pressure in the presence of a catalyst including 15-50% wt cobalt at least partially in elemental form, supported on an oxidic support of aluminium, oxygen and 0.5-10% wt lithium, where the oxidic support includes lithium oxides and >75% wt of the lithium oxides are lithium aluminate spinel, LiAl 5 O 8 .

  一种通过费舍尔-特罗普斯合成反应合成烃的工艺，包括在催化剂的存在下，在高温高压下反应一种一氧化碳和氢的混合物，所述催化剂包括15-50%重量的钴，至少部分以元素形式存在，负载在氧化铝的氧化物支撑体上，该氧化物支撑体包括氧化锂和0.5-10%重量的锂，其中，氧化物支撑体包括氧化锂和>75%重量的氧化锂是氧化铝尖晶石LiAl5O8。
• Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors
  申请人：Bardiot Dorothée

  公开号：US08785638B2

  公开（公告）日：2014-07-22

  The present invention relates to a series of compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutic amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

  本发明涉及一系列具有抗病毒活性的化合物，更具体地说是具有抑制人类免疫缺陷病毒(HIV)复制的性质。本发明还涉及制备这种化合物的方法，以及在这些合成步骤中有用的新中间体。本发明还涉及包含这种化合物作为活性成分的有效量药物组合物。本发明进一步涉及将这种化合物用作药物或制造药物，用于治疗患有病毒感染的动物，特别是HIV感染。本发明还涉及通过给予这种化合物的治疗剂量，可选地与一种或多种具有抗病毒活性的其他药物联合使用，治疗动物的病毒感染的方法。